Hyeon-Kyoung Koo

Dr. Hyeon-Kyoung Koo

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
MJMoa Jeong
Moa Jeong
HKHyung Koo Kang
Hyung Koo Kang
PSPamela Song
Pamela Song
HPHye Kyeong Park
Hye Kyeong Park
HJHoon Jung
Hoon Jung
HKHyeon-Kyoung Koo
Hyeon-Kyoung Koo
Purpose: Hand grip strength (HGS) is a simple way of predicting the risk of cardiovascular disease and all-cause mortality in the general population. However, the practical significance of grip strength in patients with COPD is uncertain. The aim of this study was to compare HGS between subjects with and without COPD and to evaluate its clinical relevance in patients with COPD by using a national survey. Methods: Data were collected from the Korean National Health and Nutrition Examination Survey. The study included 421 adults with COPD and 2,542 controls who completed questionnaires, spirometry, and a HGS test. HGS was compared between subjects with and without COPD, and the association between grip strength, lung function, and quality of life (QoL) was evaluated. Results: The mean HGS was 33.3±9.1 kg in the COPD group and 29.9±9.5 kg in the non-COPD group; adjusted HGS was 30.9±0.33 kg and 30.9±0.11 kg, respectively (P=0.99). HGS was not related to forced vital capacity (β=0.04, P=0.70) or forced expiratory volume in 1 second (β=0.11, P=0.24) in multivariable analysis. HGS was independently associated with the EQ-5D index, but the relationship was stronger in the COPD group (β=0.30, P<0.001) than in the non-COPD group (β=0.21, P<0.001). The results were similar for each component of the EQ-5D, including mobility (β=-0.25, P<0.001), daily activity (β=-0.19, P=0.01), pain/discomfort (β=-0.32, P<0.001), and anxiety/depression (β=-0.16, P=0.01). Conclusion: HGS was not different between subjects with and without COPD, but was associated with QoL – including mobility, daily activity, pain/discomfort, and anxiety/depression – in patients with COPD. The HGS test could be used as a marker of QoL in patients with COPD and could assist risk stratification in clinical practice.

24 August 2020 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
HKHyeon-Kyoung Koo
Hyeon-Kyoung Koo
JMJinsoo Min
Jinsoo Min
HKHyung Woo Kim
Hyung Woo Kim
JLJoosun Lee
Joosun Lee
JKJu Sang Kim
Ju Sang Kim
SLSung-Soon Lee
Sung-Soon Lee
Background: To improve treatment outcomes for tuberculosis (TB), efforts to reduce treatment failure are necessary. The aim of our study was to describe the characteristics of subjects who had failed treatment of tuberculosis and identify the risk factors for treatment failure and poor compliance using national data. Methods: A multicenter cross-sectional study was performed on tuberculosis subjects whose final outcome was reported as treatment failure during 2015–2017. The same number of subjects with treatment success during the same study period were randomly selected for comparison. Demographics, microbiological, radiographic, and clinical data were collected based on in-depth interviews by TB nurse specialists at all Public Private Mix (PPM) participating hospitals in South Korea. Results: A total of 52 tuberculosis patients with treatment failure were enrolled. In a multivariable analysis, the presence of diabetes, previous history of tuberculosis, and cavity were identified as risk factors for treatment failure; and Medicaid support was a favorable factor for treatment success (area under the curve [AUC]: 0.79). Age, low body mass index (BMI), presence of diabetes, preexisting lung disease, positive sputum acid-fast bacilli (AFB) smear result, and the presence of multidrug-resistant tuberculosis (MDR-TB) were significantly associated with presence of cavities. Younger age, lower BMI and previous history of TB were associated with poor compliance during treatment (AUC: 0.76). Conclusion: To reduce treatment failure, careful evaluation of the presence of diabetes, previous TB history, underlying lung disease, cavity, results of sputum AFB smears, and socioeconomic status are needed. To enhance treatment compliance, more attention should be paid to younger patients with lower BMIs during follow-up.

22 September 2020 in Epigenetics
Verified
Journal Article
Open access
HKHyeon-Kyoung Koo
Hyeon-Kyoung Koo
JMJarrett Morrow
Jarrett Morrow
PKPriyadarshini Kachroo
Priyadarshini Kachroo
KTKelan Tantisira
Kelan Tantisira
SWScott T. Weiss
Scott T. Weiss
DDDawn L. DeMeo
Dawn L. DeMeo
Cigarette smoking impacts DNA methylation, but the investigation of sex-specific features of lung tissue DNA methylation in smokers has been limited. Women appear more susceptible to cigarette smoke, and often develop more severe lung disease at an earlier age with less smoke exposure. We aimed to analyse whether there are sex differences in DNA methylation in lung tissue and whether these DNA methylation marks interact with smoking. We collected lung tissue samples from former smokers who underwent lung tissue resection. One hundred thirty samples from white subjects were included for this analysis. Regression models for sex as a predictor of methylation were adjusted for age, presence of COPD, smoking variables and technical batch variables revealed 710 associated sites. 294 sites demonstrated robust sex-specific methylation associations in foetal lung tissue. Pathway analysis identified 6 nominally significant pathways including the mitophagy pathway. Three CpG sites demonstrated a suggested interaction between sex and pack-years of smoking: GPR132, ANKRD44 and C19orf60. All of them were nominally significant in both male- and female-specific models, and the effect estimates were in opposite directions for male and female; GPR132 demonstrated significant association between DNA methylation and gene expression in lung tissue (P < 0.05). Sex-specific associations with DNA methylation in lung tissue are wide-spread and may reveal genes and pathways relevant to sex differences for lung damaging effects of cigarette smoking.

19 September 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
JMJinsoo Min
Jinsoo Min
JKJu Sang Kim
Ju Sang Kim
HKHyung Woo Kim
Hyung Woo Kim
YKYousang Ko
Yousang Ko
JOJee Youn Oh
Jee Youn Oh
HKHyeon-Kyoung Koo
Hyeon-Kyoung Koo
Background: Poor nutrition increases disease severity and mortality in patients with tuberculosis (TB). There are gaps in our understanding of the effects of being underweight or overweight on TB in relation to sex.Methods: We generated a nationwide TB registry database and assessed the effects of body mass index (BMI) on mortality in patients with pulmonary TB. The cause of death was further classified as TB-related or non-TB-related deaths. First, logistic regression analysis was performed to assess the association between BMI (a continuous variable) and mortality, and subgroup analyses of the multivariable logistic regression model were performed separately in male and female patients. Second, we categorized BMI into three groups: underweight, normal weight, and overweight, and assessed the impact of being underweight or overweight on mortality with reference to normal weight.Results: Among 9,721 patients with pulmonary TB, the mean BMI was 21.3 ± 3.4; 1,927 (19.8%) were underweight, and 2,829 (29.1%) were overweight. In multivariable logistic regression analysis, mortality was significantly increased with the decrement of BMI (adjusted odds ratio [aOR] = 0.893, 95% confidence interval [CI] = 0.875–0.911). In subgroup analyses, underweight patients had significantly higher odds of mortality, especially TB-related deaths (aOR = 2.057, 95% CI = 1.546–2.735). The association with mortality and male patients was higher (aOR = 2.078, 95% CI = 1.717–2.514), compared with female patients (aOR = 1.724, 95% CI = 1.332–2.231). Being overweight had a significant protective effect against TB-related death only in females (aOR = 0.500, 95% CI = 0.268–0.934), whereas its effect on non-TB-related death was observed only in males (aOR = 0.739, 95% CI = 0.587–0.930).Conclusion: Being underweight was linked to high mortality, whereas being overweight had beneficial effects in patients with pulmonary TB.

13 April 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JMJinsoo Min
Jinsoo Min
JPJae Seuk Park
Jae Seuk Park
HKHyung Woo Kim
Hyung Woo Kim
YKYousang Ko
Yousang Ko
JOJee Youn Oh
Jee Youn Oh
HKHyeon-Kyoung Koo
Hyeon-Kyoung Koo
Disparities exist between sexes regarding tuberculosis (TB) incidence, as well as disease severity and outcome. Using a nationwide TB registry database, we explored the impact of sex and age on extrapulmonary TB (EPTB) among all enrolled patients by (1) calculating the female proportion for every age category according to TB-affected locations, (2) calculating the proportions of EPTB stratified by sex according to age, (3) conducting multivariable analysis to examine the impact of sex and age on EPTB likelihood, and (4) assessing the odds of EPTB for female compared to male as reference in every age category. Further, we explored the impact of sex and age on disease severity among pulmonary TB (PTB) patients. Of all the TB patients, 40.1% were female, with a male-to-female ratio of 1.49. The proportion of females was lowest in their fifties, resembling a U-shape. The male-to-female ratios in PTB and EPTB were 1.67 and 1.03, respectively. Compared to men, women were significantly associated with EPTB in their forties, fifties, and sixties. Female patients with PTB had significantly lower odds of having cavitation and positive smear test results in their fifties. Significant differences were found concerning TB location and severity between sexes, especially during reproductive age.

25 January 2019 in Respirology
Verified
Journal Article
Closed access
PDF file
HKHyeon-Kyoung Koo
Hyeon-Kyoung Koo
IJIna Jeong
Ina Jeong
JKJoo‐Hee Kim
Joo‐Hee Kim
SKSung‐Kyoung Kim
Sung‐Kyoung Kim
JSJong‐Wook Shin
Jong‐Wook Shin
ODon behalf of the Cough Study Group of the Korean Academy of Tuberculosis and Respiratory Diseases
on behalf of the Cough Study Group of the Korean Academy of Tuberculosis and Respiratory Diseases